Clinical Trials Logo

Cognitive Performance clinical trials

View clinical trials related to Cognitive Performance.

Filter by:

NCT ID: NCT06395051 Not yet recruiting - Clinical trials for Cognitive Performance

Effects of Ketone Monoesters on Brain Function

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Disturbances in brain insulin-sensitivity are not only observed in obesity and type 2 diabetes (T2D), but also during brain aging and in dementia. Ketone monoester supplements may improve brain insulin-sensitivity, which can be quantified by measuring the gray-matter cerebral blood flow (CBF) response to intranasally administered insulin. We hypothesize that acute ketone monoester supplementation increases (regional) brain vascular function and insulin-sensitivity thereby improving cognitive performance and appetite control. The primary objective is to evaluate in older men the acute effect of ketone monoester supplementation on (regional) brain vascular function and insulin-sensitivity, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI)-perfusion method Arterial Spin Labelling (ASL). The CBF response to intranasal insulin is a robust and sensitive physiological marker of brain insulin-sensitivity. Secondary objectives are to investigate effects on cognitive performance as assessed with a neuropsychological test battery, and appetite control as quantified by functional MRI (fMRI) with visual food cues.

NCT ID: NCT06390267 Not yet recruiting - Clinical trials for Cognitive Performance

Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction

ASR
Start date: August 2024
Phase: N/A
Study type: Interventional

The objective of this study is to test the effects of transcutaneous auricular neurostimulation (tAN) in treating or preventing performance degradation after an acute stressor.

NCT ID: NCT06380582 Not yet recruiting - Clinical trials for Cognitive Performance

Indoor Air Quality, Temperature and Cognitive Performance

AEOLUS
Start date: April 25, 2024
Phase: N/A
Study type: Interventional

Study design: A cross-over single-blinded treatment design will be used. Participants will undergo 4 different conditions: (1) low air flow and 23°C, (2) low air flow and 35°C, (3) high air flow and 23°C, and (4) high air flow and 35°C. Participants will be blinded to the air quality level; however, it is not possible to blind them to the temperature condition, as they will be able to perceive it as different. Study population: The population consists of healthy young and middle-aged adults of both sexes between 18 and 40 years. Intervention (if applicable): Each participant undergoes 4 conditions in randomized order. Two conditions consist of poor air quality defined as 3,000 ppm carbon dioxide and 23°C or 35°C temperature, respectively.

NCT ID: NCT06343142 Recruiting - Clinical trials for Cognitive Performance

Effects of Time of Day and Nut Intake on Cognitive Performance

Start date: April 8, 2024
Phase: N/A
Study type: Interventional

This is a 2 x 2-factor crossover design study to investigate the effects of time of day and nuts on post-meal cognitive performance.

NCT ID: NCT06127511 Not yet recruiting - Inflammation Clinical Trials

Peanut Consumption on Cognitive, Weight, and Inflammation

PEANUTY
Start date: January 2024
Phase: N/A
Study type: Interventional

A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.

NCT ID: NCT05904431 Not yet recruiting - Clinical trials for Cognitive Performance

The Effect of Cognitive Performance on Physical Performance in Adolescent Basketball Players

Start date: June 30, 2023
Phase:
Study type: Observational

The aim of this study is to examine the relationship between physical fitness parameters and cognitive performance levels in basketball players. It has been shown in the literature that exercise has an effect on cognitive factors. However, there is a limited number of studies examining the relationship between physical performance parameters and cognitive performance in basketball players.

NCT ID: NCT05724654 Active, not recruiting - Clinical trials for Cognitive Performance

Effects of Peanut Consumption on Brain Function

Start date: February 8, 2023
Phase: N/A
Study type: Interventional

Impaired brain vascular function precedes the development of reduced cognitive performance, while brain insulin-resistance is also associated with cognitive decline. Peanut consumption has already been shown to beneficially affect cognitive performance. However, underlying mechanisms have not yet been established, while well-controlled trials on longer-term effects of peanuts on cognitive performance are highly needed. The hypothesis is that longer-term peanut consumption has beneficial effects on (regional) cerebral blood flow responses (primary outcome), which may relate to an improved cognitive performance (secondary outcome) in older men and women. Important objectives are to investigate in older adults the effect of 16-week peanut consumption on (i) brain vascular function in cognitive-control brain areas, and (ii) brain insulin-sensitivity. We will also focus on changes in cognitive performance as assessed with a neuropsychological test battery (secondary objective). Cerebral blood flow responses before (brain vascular function) and after the administration of intranasal insulin (brain insulin sensitivity) will be non-invasively quantified by the non-invasive gold standard magnetic resonance imaging (MRI)-perfusion method Arterial Spin Labeling (ASL).

NCT ID: NCT05653141 Recruiting - Clinical trials for Cognitive Performance

Post-stroke Cognitive Impairment

CogStroke
Start date: December 17, 2020
Phase:
Study type: Observational

Present study aims to track the post-stroke cognitive trajectories and to investigate its inter-individual variability.

NCT ID: NCT05598047 Recruiting - Aging Clinical Trials

Executive Functioning Training Study

EFT
Start date: June 13, 2023
Phase: Phase 2
Study type: Interventional

Cognitive aging in people with HIV (PWH) is of increasing concern for several reasons: 1) between 52%-59% of PWH experience cognitive impairment known as HIV-Associated Neurocognitive Disorder (HAND) which impacts everyday functioning and quality of life; 2) HAND increases in severity and prevalence with age; and 3) 70% of PWH in the United States will be 50 and older by 2030. Fortunately, cognitive training programs can individually target specific cognitive impairments in PWH and possibly reduce the severity and prevalence of HAND and improve everyday functioning and quality of life. This approach is based around the underlying concept of intra-individual variability as controlled through higher level allocation of cognitive resources, known as executive functioning. This feasibility study will use a two-group pre-post experimental design of adults with HAND including: 1) a 20-hours of Executive Functioning Training group (enroll 60, n=48 with attrition), and 2) a no-contact control (enroll 60, n=48 with attrition). Aim 1 - Feasibility: To determine feasibility and acceptability of the intervention (i.e., attrition, feedback). Exploratory Aim 1 - Cognition: Compare adults who receive Executive Functioning Training to those who receive no training to determine whether they improve in global cognitive ability and overall cognitive IIV. This high impact study is innovative in the following ways: 1) This is the first study aimed to reduce cognitive IIV in PWH. 2) This is the first study to use IIV as a guide to target solely executive functioning training to improve global cognitive ability, which may reduce the severity and prevalence of HAND. 3) Over the last decade, the epicenter of HIV has emerged in the Deep South where this study will occur. Most participants in this study will be older PWH who identify as lower social economic status (SES) and/or African Americans and experience HAND symptoms.

NCT ID: NCT05541887 Recruiting - Anxiety Clinical Trials

Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating inflammation and oxidative stress, and/or inhibiting monoamine oxidase activities